These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors. Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208 [TBL] [Abstract][Full Text] [Related]
4. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. Siitonen SM; Kallioniemi OP; Isola JJ Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759 [TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma. Tanioka F; Hiroi M; Yamane T; Hara H Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885 [TBL] [Abstract][Full Text] [Related]
6. Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Fontanini G; Pingitore R; Bigini D; Vignati S; Pepe S; Ruggiero A; Macchiarini P Am J Pathol; 1992 Dec; 141(6):1285-90. PubMed ID: 1361306 [TBL] [Abstract][Full Text] [Related]
7. Comparative flow cytometric analysis of proliferating cell nuclear antigen (PCNA) antibodies in human solid neoplasms. Teague K; el-Naggar A Cytometry; 1994 Jan; 15(1):21-7. PubMed ID: 7909288 [TBL] [Abstract][Full Text] [Related]
8. Comparative flow cytometric analysis of Ki-67 and proliferating cell nuclear antigen (PCNA) in solid neoplasms. Steck K; el-Naggar AK Cytometry; 1994 Nov; 17(3):258-65. PubMed ID: 7851161 [TBL] [Abstract][Full Text] [Related]
9. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53. Oshiro Y; Fukuda T; Tsuneyoshi M Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104 [TBL] [Abstract][Full Text] [Related]
10. Proliferative activity determined by DNA flow cytometry and proliferating cell nuclear antigen (PCNA) immunohistochemistry as a prognostic factor in prostatic carcinoma. Visakorpi T J Pathol; 1992 Sep; 168(1):7-13. PubMed ID: 1360498 [TBL] [Abstract][Full Text] [Related]
11. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas. Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables. Frierson HF Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204 [TBL] [Abstract][Full Text] [Related]
14. Cell cycle dependent distribution of proliferating cell nuclear antigen/cyclin and cdc2-kinase in mouse T-lymphoma cells. Brott DA; Alvey JD; Bleavins MR; de la Iglesia FA; Lalwani ND J Cell Biochem; 1993 Jul; 52(3):362-72. PubMed ID: 8103524 [TBL] [Abstract][Full Text] [Related]
15. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen. Yu CC; Dublin EA; Camplejohn RS; Levison DA Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754 [TBL] [Abstract][Full Text] [Related]
16. Clonality assessment of lymphoproliferative disorders by multiparameter flow cytometry of paraffin-embedded tissue: an additional diagnostic tool in surgical pathology. Leers MP; Theunissen PH; Ramaekers FC; Schutte B; Nap M Hum Pathol; 2000 Apr; 31(4):422-7. PubMed ID: 10821487 [TBL] [Abstract][Full Text] [Related]
17. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index. Khine MM; Aung W; Sibbons PD; Howard CV; Clapham E; McGill F; Van Velzen D Lab Invest; 1994 Jan; 70(1):125-9. PubMed ID: 7905542 [TBL] [Abstract][Full Text] [Related]
18. DNA analysis of head and neck squamous cell carcinoma by flow cytometry. Lampe HB Laryngoscope; 1993 Jun; 103(6):637-44. PubMed ID: 8099190 [TBL] [Abstract][Full Text] [Related]
19. Proliferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. Dervan PA; Magee HM; Buckley C; Carney DN Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S21-8. PubMed ID: 1349455 [TBL] [Abstract][Full Text] [Related]
20. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics. Swanson SA; Brooks JJ Am J Pathol; 1990 Dec; 137(6):1491-500. PubMed ID: 1979714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]